APOGEE THERAPEUTICS INC (APGE) Stock Income Statement
USA - NASDAQ:APGE - US03770N1019 - Common Stock
38.42 USD
+0.29 (+0.76%)
38.42 USD
0 (0%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 270.83M | 216.87M | 93.00M | 30.73M | |||
| Research and Development | 208.03M | 167.87M | 68.42M | 27.79M | |||
| Selling, General, and Administrative Expenses | 62.80M | 49.01M | 24.58M | 2.94M | |||
| Operating Income | -270.83M | -216.87M | -93.00M | -30.73M | |||
| Interest Income/Expense | 33.33M | 34.74M | 9.02M | 92.00K | |||
| Other Income/Expense | N/A | N/A | N/A | -9.15M | |||
| Income Before Taxes | -237.50M | -182.13M | -83.98M | -39.78M | |||
| Income Tax | N/A | 18.00K | N/A | N/A | |||
| Net Income | -237.67M | -182.15M | -83.98M | -39.78M | |||
| EBITDA | -270.10M | -216.68M | N/A | N/A | |||
| Per Share Data | |||||||
| EPS Diluted Total Ops | -4.12 | -3.30 | -1.74 | -0.84 | |||
| Non GAAP EPS | -4.13 | -3.29 | N/A | N/A | |||
| Statistics | |||||||
All data in USD